[Clinical and experimental validation of the use of the tranquilizer mebikar as a corrective of the neuroleptic syndrome].
The results of the experimental and clinical studies showed that administration of mebikar in combination with neuroleptics reduced the degree of side effects of the neuroleptics without decreasing their antipsychotic effect.